David A. Montecalvo
2018
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $30,296 |
|---|---|
| Non-Equity Incentive Plan | $264,290 |
| Option Awards | $400,037 |
| Salary | $401,461 |
| Stock Awards | $407,135 |
| Other | $16,392 |
| Total | $1,519,611 |
Montecalvo received $407.1K in stock awards, accounting for 27% of the total pay in 2018.
Montecalvo also received $30.3K of change in pension value and nonqualified deferred compensation earnings, $264.3K in non-equity incentive plan, $400K in option awards, $401.5K in salary and $16.4K in other compensation.
Rankings
In 2018, David A. Montecalvo's compensation ranked 7,097th out of 14,244 executives tracked by ExecPay. In other words, Montecalvo earned more than 50.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,097 out of 14,244 | 50th |
Division Manufacturing | 2,728 out of 5,759 | 53rd |
Major group Rubber And Miscellaneous Plastics Products | 58 out of 107 | 46th |
Industry group Fabricated Rubber Products, Not Elsewhere | 12 out of 22 | 46th |
Montecalvo's colleagues
We found six more compensation records of executives who worked with David A. Montecalvo at West Pharmaceutical Services in 2018.
2018
Eric Green
West Pharmaceutical Services
Chief Executive Officer
2018
Bernard Birkett
West Pharmaceutical Services
Chief Financial Officer
2018
William Federici
West Pharmaceutical Services
Chief Financial Officer
2018
Karen Flynn
West Pharmaceutical Services
SVP & Chief Commercial Officer
2018
Silji Abraham
West Pharmaceutical Services
SVP & Chief Digital Transformation Officer
2018
George Miller
West Pharmaceutical Services
General Counsel
News
April 14, 2022
March 24, 2021
March 25, 2020
March 22, 2019